Executive Summary
The PTAB has instituted an inter partes review of Inari Medical’s hemostasis valve patent after finding Imperative Care’s petition shows a reasonable likelihood of success. The review will cover claims 1‑9 and is based on anticipation and obviousness grounds over Schaffer, Hartley, and Eller references.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Imperative Care, Inc. vs Inari Medical, Inc. et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Wybotics Inc. et al.vsZodiac Pool Systems LLC
Wybotics petitions the PTAB to invalidate Zodiac Pool Systems' pool‑cleaning patent, asserting that the claims are anticipated by a 2007 Chinese filing and obvious over multiple U.S. robot‑cleaner references. The petition seeks institution of the IPR on claims 1‑3.
Dr. Reddy's Laboratories S.A. et al.vsEye Therapies, LLC et al.
Dr. Reddy’s labs and Eye Therapies have jointly filed a motion to keep their settlement agreement confidential and separate from the IPR docket. The request cites statutory authority and seeks limited disclosure.
Toyota Motor Corp. et al.vsEmerging Automotive LLC
Toyota Motor Corp. challenges U.S. Patent No. 11,396,244 in an IPR proceeding against Emerging Automotive LLC, asserting obviousness under 35 U.S.C. § 103. The petition argues that combinations of prior art references (Rector, Kleve, Yassin) disclose the claimed cloud services for vehicle customization and security features.
Nike, Inc.vsSherryWear, LLC
Nike successfully petitioned to challenge seven claims of SherryWear's patent based on obviousness over prior art references including Spagna and Rose. The Board found a reasonable likelihood of success regarding claim 1, leading to the institution of the IPR.
Askeladden L.L.C.vsIntercurrency Software LLC
Petitioner Askeladden L.L.C. filed an IPR challenging patent 10776863 held by Intercurrency Software LLC, asserting obviousness under 35 U.S.C. §103. The challenge focuses on the combination of electronic trading features and currency conversion methods in financial technology.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.